In conversation with...

Dr. Tina Hartert discusses a new study that aimed to evaluate the strength for a causal effect of Respiratory Syncytial Virus-Lower Respiratory Tract Infection (RSV-LRTI) in subsequent chronic wheezing illness to inform public health expectations for RSV vaccines.

Authors of a new population-based study on the association between antibiotic use in infancy and risk of asthma later in life discuss the results of their trial and how they might influence paediatricians and parents.

David Maslove and Daniel E. Leisman discuss their recent paper published in Critical Care Medicine discussing guidance on the development of prediction models for critical care

Don Sin discusses a new tool for clinicians to use to detect potential exacerbations in patients with chronic obstructive pulmonary disorder.

Authors of the MERGE Trial discuss treatment of mild obstructive sleep apnea and the effectiveness of continuous positive airway pressure, or CPAP, in the treatment of patients with mild OSA

Authors from a new case series talk about the development of an algorithm they developed for the diagnosis and treatment of e-cigarette or vaping product use-associated lung injury, or EVALI.

Dr. Marcelo Cypel discusses a trial looking at lung transplantation from Hepatitis C viremic donors.

Dr Scott Bell and Dr Felix Ratjen discuss The Lancet Respiratory Medicine's Cystic Fibrosis Commission on the future of cystic fibrosis care.

Dr. Luca Richeldi discusses a trial looking at pamrevlumab, an anti-connective tissue growth factor therapy for the treatment of idiopathic pulmonary fibrosi

Dr. Natalie Walker discusses a trial she and her colleagues conducted looking at the effectiveness of nicotine patches used in conjunction with e-cigarettes for smoking cessation.